Annual EBIT
-$30.03 M
+$9.72 M+24.46%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual earnings before interest & taxes is -$30.03 million, with the most recent change of +$9.72 million (+24.46%) on December 31, 2023.
- During the last 3 years, NRXP annual EBIT has risen by +$21.69 million (+41.94%).
- NRXP annual EBIT is now at all-time high.
Performance
NRXP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.62 M
+$6.27 M+79.45%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly earnings before interest & taxes is -$1.62 million, with the most recent change of +$6.27 million (+79.45%) on September 30, 2024.
- Over the past year, NRXP quarterly EBIT has increased by +$4.67 million (+74.23%).
- NRXP quarterly EBIT is now -1648.66% below its all-time high of $104.80 thousand, reached on June 30, 2020.
Performance
NRXP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$20.07 M
+$4.40 M+17.98%
September 30, 2024
Summary
- As of February 8, 2025, NRXP TTM earnings before interest & taxes is -$20.07 million, with the most recent change of +$4.40 million (+17.98%) on September 30, 2024.
- Over the past year, NRXP TTM EBIT has increased by +$5.22 million (+20.64%).
- NRXP TTM EBIT is now -19250.76% below its all-time high of $104.80 thousand, reached on June 30, 2020.
Performance
NRXP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NRXP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.5% | +74.2% | +20.6% |
| 3 y3 years | +41.9% | +82.1% | +66.5% |
| 5 y5 years | +41.9% | +68.5% | -297.9% |
NRXP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.7% | at high | +94.7% | at high | +78.4% |
| 5 y | 5-year | at high | +67.7% | -1648.7% | +96.4% | <-9999.0% | +81.4% |
| alltime | all time | at high | +67.7% | -1648.7% | +96.4% | <-9999.0% | +81.4% |
NRx Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.62 M(-79.4%) | -$20.07 M(-18.0%) |
| Jun 2024 | - | -$7.90 M(+25.4%) | -$24.47 M(-3.2%) |
| Mar 2024 | - | -$6.30 M(+48.1%) | -$25.29 M(-15.8%) |
| Dec 2023 | -$30.03 M(-24.5%) | -$4.25 M(-29.4%) | -$30.03 M(-16.6%) |
| Sep 2023 | - | -$6.02 M(-30.9%) | -$36.02 M(-7.8%) |
| Jun 2023 | - | -$8.72 M(-21.0%) | -$39.08 M(+4.6%) |
| Mar 2023 | - | -$11.04 M(+7.8%) | -$37.35 M(-6.1%) |
| Dec 2022 | -$39.75 M | -$10.24 M(+12.8%) | -$39.75 M(-33.6%) |
| Sep 2022 | - | -$9.08 M(+30.1%) | -$59.91 M(-31.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.98 M(-48.1%) | -$87.88 M(+8.5%) |
| Mar 2022 | - | -$13.45 M(-55.8%) | -$81.01 M(-12.9%) |
| Dec 2021 | -$93.05 M(+79.9%) | -$30.41 M(-17.9%) | -$93.05 M(-13.7%) |
| Sep 2021 | - | -$37.04 M(>+9900.0%) | -$107.76 M(+42.0%) |
| Jun 2021 | - | -$113.00 K(-99.6%) | -$75.87 M(+0.3%) |
| Mar 2021 | - | -$25.48 M(-43.5%) | -$75.65 M(+50.8%) |
| Dec 2020 | -$51.72 M | -$45.12 M(+776.3%) | -$50.17 M(+894.5%) |
| Sep 2020 | - | -$5.15 M(-5013.4%) | -$5.04 M(-4913.4%) |
| Jun 2020 | - | $104.80 K | $104.80 K |
FAQ
- What is NRx Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual EBIT year-on-year change?
- What is NRx Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly EBIT year-on-year change?
- What is NRx Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM EBIT year-on-year change?
What is NRx Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of NRXP is -$30.03 M
What is the all time high annual EBIT for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual earnings before interest & taxes is -$30.03 M
What is NRx Pharmaceuticals annual EBIT year-on-year change?
Over the past year, NRXP annual earnings before interest & taxes has changed by +$9.72 M (+24.46%)
What is NRx Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of NRXP is -$1.62 M
What is the all time high quarterly EBIT for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly earnings before interest & taxes is $104.80 K
What is NRx Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, NRXP quarterly earnings before interest & taxes has changed by +$4.67 M (+74.23%)
What is NRx Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of NRXP is -$20.07 M
What is the all time high TTM EBIT for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM earnings before interest & taxes is $104.80 K
What is NRx Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, NRXP TTM earnings before interest & taxes has changed by +$5.22 M (+20.64%)